Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
http://www.fda.gov/cder/orange/appendix_a.txt ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - - EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE1 -SE7)* and EFFICACY SUPPLEMENTS APPROVED IN CALENDAR YEAR 2003 (SE8)* - GENERIC NAME APPLICANT NDA NUMBER SUPP TYPE SUPP NUMBER RECEIPT DATE APPROVAL DATE PRIORITY REVIEW TOTAL APPROVAL TIME (MONTHS) INDICATION/DESCRIPTION FLUOXETINE...
21-437_Inspra.htm Food and Drug Administration • Center for Drug Evaluation and Research Title Search Inspra (Eplerenone) Tablets Company:--G.D
author: USERNAME
CDER 2002 Report to the Nation; Drug Review Food and Drug Administration • Center for Drug Evaluation and Research About CDER - Report Search CDER Report to the Nation: 2002 Table of Contents Adobe Acrobat version of this document 1 Drug Review Index Mission Highlights New Drug Review List of priority new drugs List of new molecular entities List of orphan new drugs New Drug Review Statistics Priority new drug statistics...
author: OLIVERN
NMEs Approved in CY 2002 NMEs Approved in Calendar Year 2002 - NDA Number Generic Name Trade Name Dosage Form Applicant *Classification Approval Date 21-232 Nitisinone Orfadin Capsule Swedish Orphan -- 1PV 01-18-2002 21-286 Olmesartan Medoxomil Benicar Tablet Sankyo- 1S 04-25-2002 21-344 Fulvestrant Faslodex Injection AstraZeneca 1S 04-25-2002 21-272 Treprostinil Sodium Remodulin Injection United...
author: Susan Daugherty
Prescription and OTC Drug Product List 9/2002 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST -A- ADEFOVIR DIPIVOXIL -A- TABLET; ORAL -A- HEPSERA -A- + GILEAD 10MG N21449 001 SEP 20, 2002 SEP NEWA ALBUTEROL SULFATE TABLET, EXTENDED RELEASE; ORAL -A- ALBUTEROL SULFATE -A- AB SIDMAK LABS EQ 4MG BASE N76130 002 SEP 26, 2002 SEP NEWA -A- AB EQ 8MG BASE N76130 003 SEP 26, 2002 SEP NEWA VOLMAX -D- BC + MURO EQ 4MG BASE N19604...
http://www.fda.gov/cder/foi/label/2002/21437lbl.pdf O COOCH 3 O Eplerenone O O INSPRA (eplerenone tablets) Amended Proposed US PI September 27, 2002 PHA Version 4 INSPRA for oral administration contains 25 mg, 50 mg, or 100 mg of eplerenone and the following inactive ingredients: lactose, microcrystalline cellulose, croscarmellose sodium, hydroxypropyl methylcellulose, sodium lauryl sulfate, talc, magnesium stearate,...
http://www.fda.gov/cder/foi/label/2002/21437lbl.pdf page 16
http://www.fda.gov/cder/foi/label/2002/21437lbl.pdf page 12
http://www.fda.gov/cder/foi/label/2002/21437lbl.pdf page 9
http://www.fda.gov/cder/foi/label/2002/21437lbl.pdf page 4
http://www.fda.gov/cder/foi/label/2002/21437lbl.pdf page 3
http://www.fda.gov/cder/foi/label/2002/21437lbl.pdf page 2
http://www.fda.gov/cder/foi/label/2002/21437lbl.pdf page 1
Index E, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - INDEX - Index-A -~ Index-B -~ Index-C -~ Index-D -~ Index-E-~ Index-F -~ Index-G -~ Index-H -~ Index-I -~ Index-J -~ Index-K -~ Index-L -~ Index-M -~ Index-N -~ Index-O ...
Heart Failure, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - SECTION 3 Medical Conditions CHAPTER 46 - Heart Failure TOPICS - Heart Failure - Heart Failure Heart failure develops when the heart cannot pump as much blood as the...
THE MERCK MANUAL OF GERIATRICS, Index E - Index Index-A -| Index-B -| Index-C -| Index-D -| Index-E -| Index-F -| Index-G -| Index-H -| Index-I -| Index-J &n; bsp;| Index-K -| Index-L -| Index-M -| Index-N -| Index-O -| Index-P -| Index-Q -| Index-R -| Index-S -| Index-T -| Index-U -| Index-V -| Index-W -| Index-X,Y,Z Index E Eagle's syndrome 1350 Earache 133 3-1334 Ears (see also Hearing ) acoustic neuroma of 1341-1342...
Database E E - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act NOTE: This list simply identifies approved active moieties to which FDA has issued a Written Request for pediatric studies since June 1998
Microsoft Word - 1-8-04.doc Medical Grand Rounds January 8, 2004 Department of Internal Medicine Aldosterone: changing concepts and therapies by John B.
author: strommerl
Microsoft Word - 1-8-04.doc page 2
author: strommerl
Patent and Exclusivity Terms HEPATITIS C U-376 TREATMENT OF INFLUENZA U-377 METHOD OF TREATING PT WITH CHRONIC HEPATITIS C HAVING HCV GENOTYPE 1 AND VIRAL LOAD GREATER THAN 2 MILLION COPIES/ML TO ERADICATE DETECTABLE HCV-RNA BY ADMIN COMBINATION OF RIBAVIRIN AND INTERFERON ALFA-2B FOR A LEAST 24 WEEKS U-378 METHOD FOR TREATING INCONTINENCE U-379 METHOD OF TREATING ONYCHROMYCOSIS U-380 COMBINATIONS OF TAXOL ...
http://www.adis.com/files/newsletters/INP/Icov1417.pdf 24 Posaconazole: superior outcomes in invasive aspergillosis 10 ALLERGY Sulfamethizole: increased risk of miscarriage
